• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Food & Drug Administration (FDA)

First OTC molecular test for COVID-19 gains FDA nod

March 5, 2021 By Nancy Crotti Leave a Comment

The FDA today issued its first emergency use authorization for a molecular COVID-19 diagnostic test for at-home use without a prescription. The Cue Health COVID-19 Test for Home and Over The Counter (OTC) use is a molecular nucleic acid amplification test designed to detect genetic material from the SARS-CoV-2 virus in the nostrils. The authorized […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Cue Health, FDA

Second Sight gains FDA nod for retinal system that may never be produced

March 5, 2021 By Nancy Crotti Leave a Comment

Second Sight Medical  (NSDQ: EYES) today announced that the FDA has approved its Argus 2s retinal prosthesis system, but questions remain about whether it will ever be manufactured. The past year has been tough for Second Sight. The company announced in March 2020 that it would wind down its operations amid the financial shock of […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Neuromodulation/Neurostimulation, Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Pixium Vision, Second Sight, second-sight-medical

Abbott wins EUA for COVID-19, flu, RSV combo assay

March 5, 2021 By Sean Whooley Leave a Comment

Abbott (NYSE:ABT) announced today that it received FDA emergency use authorization (EUA) for its Alinity m Resp-4-Plex molecular assay. The laboratory PCR diagnostic is designed to detect and differentiate between SARS-CoV-2 (the virus causing COVID-19), influenza A, influenza B and respiratory syncytial virus (RSV) in one test. It already has CE Mark approval and is […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, FDA

ControlRad gains clearance for imaging tech to sell to Boston Sci

March 4, 2021 By Sean Whooley Leave a Comment

ControlRad announced today that it received FDA 510(k) clearance to market its ControlRad Select radiation reduction technology. Atlanta-based ControlRad’s technology uses proprietary semi-transparent filters with a user-interface tablet and imaging processing algorithms that are retrofitted onto customers’ existing Siemens Artis zee interventional imaging systems, according to a news release. ControlRad, ahead of its commercialization efforts […]

Filed Under: 510(k), Business/Financial News, Featured, Food & Drug Administration (FDA), Imaging, Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: Boston Scientific, ControlRad

FDA clears once-daily ADHD capsule from Corium

March 3, 2021 By Sean Whooley Leave a Comment

Corium (NSDQ:CORI) announced today that it received FDA approval for its once-daily Azstarys oral capsule for treating ADHD symptoms. Boston-based Corium touts its Azstarys (serdexmethylphenidate [SDX] and dexmethylphenidate [d-MPH]) drug as the first and only product containing a d-MPH oral prodrug for treating ADHD (attention deficit hyperactivity disorder) symptoms in patients aged six years and older, […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Neurological, Pediatrics, Pharmaceutical, Regulatory/Compliance Tagged With: ADHD, Corium

Origami Surgical gains FDA clearance for robotic suturing devices

March 3, 2021 By Nancy Crotti Leave a Comment

Origami Surgical today announced that the FDA has granted 510(k) clearance for three new types of sutures for its StitchKit robotic surgery platform. The company describes StitchKit as a patented suture delivery and retrieval system designed so sutures are efficiently inserted and needles are safely removed from the surgical field. StitchKit also allows the robotic […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Robotics, Surgical Tagged With: 510(k), FDA, Origami Surgical

N.J. appeals court tosses $83M pelvic mesh verdicts against J&J, Bard

March 3, 2021 By Nancy Crotti Leave a Comment

A New Jersey appeals court yesterday threw out jury verdicts totaling $83 million in separate pelvic mesh lawsuits against Johnson & Johnson’s  (NYSE:JNJ) Ethicon division and Becton Dickinson (NYSE:BDX) subsidiary C.R. Bard. In both cases, Bergen County, N.J. judges erred by disallowing evidence showing that each company’s mesh product had received FDA 510 (k) clearance, according […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Legal News, Product Liability, Regulatory/Compliance, Women's Health Tagged With: AdvaMed, becton dickinson, C.R. Bard, Ethicon, Johnson & Johnson, pelvic mesh

Abbott COVID-19 serology test gains EUA

March 3, 2021 By Sean Whooley Leave a Comment

Abbott (NYSE:ABT) this week received FDA emergency use authorization (EUA) for its AdviseDx SARS-CoV-2 IgG II diagnostic — providing another tool to detect people’s adaptive immune response to COVID-19. The serology test from Abbott Park, Ill.-based Abbott is indicated for the qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 — the virus causing COVID-19 […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, FDA

Asensus Surgical wins FDA nod for general surgery with Senhance robotic surgery system

March 3, 2021 By Sean Whooley Leave a Comment

Asensus Surgical (NYSE:TRXC), formerly TransEnterix, announced that it won expanded FDA clearance for its Senhance surgical system. Research Triangle Park, N.C.–based Asensus Surgical’s Senhance surgical system, which it touts as the first-of-its-kind digital laparoscopic platform that leverages augmented intelligence to provide strong performance and positive patient outcomes through machine learning, now has FDA clearance for […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Robotics, Surgical Tagged With: Asensus Surgical, FDA, TransEnterix

Cook Medical wins FDA breakthrough device designation for next-gen endovascular graft

March 2, 2021 By Chris Newmarker Leave a Comment

Cook Medical announced that FDA has granted breakthrough device designation for its Zenith Fenestrated+ endovascular graft (ZFEN+), the next-gen version of its Zenith Fenestrated AAA endovascular graft. The designation — a first for Bloomington, Ind.–based Cook Medical — will enable priority review and better communication with FDA during the clinical trial and premarket review phases. […]

Filed Under: Cardiovascular, Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Stents Tagged With: Cook Medical

FDA grants breakthrough nod to Anuncia’s cerebral spinal fluid treatment

March 2, 2021 By Sean Whooley Leave a Comment

Anuncia announced today that it received FDA breakthrough device designation for its ReFlow system for cerebral spinal fluid (CSF) management. Lowell, Mass.-based Anuncia’s ReFlow Mini is intended to treat CSF disorders requiring shunting, including hydrocephalus, according to a news release. It has been optimized to serve a broad hydrocephalus population, including infants with non-communicating hydrocephalus, […]

Filed Under: Featured, Food & Drug Administration (FDA), Neurological, Regulatory/Compliance, Spine Tagged With: Anuncia

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 481
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS